GRIFOLS | GRF - Ebitda





Ebitda Veränderung Datum
Alcon AG USD 795M 478M 2026-03
Almirall EUR 114.07M 60.37M 2025-12
Amadeus IT EUR 661.4M 83.5M 2026-03
Amarin USD 12.54M 28.57M 2025-06
argenx SE USD 404.12M 17.08M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Bayer EUR 4.45B 2.49B 2026-03
Cie Automotive EUR 345.96M 35.96M 2024-12
Demant DKK 2.76B 165M 2025-12
Ence Energia y Celulosa EUR 12.8M 100K 2025-12
Essilor EUR 3.09B 356M 2024-12
Ferrovial EUR 542M 607M 2025-12
Fresenius EUR 951M 283M 2026-03
Fresenius Medical Care EUR 824M 250M 2026-03
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
GRIFOLS EUR 347.45M 210K 2025-12
Hikma Pharmaceutical USD 369M 84M 2024-12
Inditex EUR 2.57B 397M 2026-03
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Merck EUR 1.53B 87M 2026-03
Novartis USD 5.3B 530M 2026-03
Philips EUR 567M 233M 2026-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
Smith & Nephew USD 796M 139M 2025-12
UCB EUR 1.6B 570M 2025-12
Viscofan EUR 63.38M 8.37M 2026-03